Indian Emtricitabine Exporters: Complete Supplier Ranking with Market Share — 141 Manufacturers (2026) — TransData Nexus

Q: Who is the largest emtricitabine supplier from India?

MYLAN LABORATORIES LIMITED is the largest emtricitabine exporter from India with a 35.6% market share and export value of $42.5M.

Q: How many emtricitabine suppliers are there in India?

There are 141 active emtricitabine exporters in India, collectively shipping $119.4M worth of emtricitabine across 2,194 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top emtricitabine suppliers from India?

The top 5 emtricitabine suppliers from India — MYLAN LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD, AUROBINDO PHARMA LTD, LUPIN LIMITED, CIPLA LIMITED — together control 83.6% of total emtricitabine export value from India.

Suresh Sormare

Emtricitabine

India Pharmaceutical Trade Intelligence

$119.4M141 Suppliers117 CountriesHS 30049099

ExportsIndia → SOUTH AFRICA26.2%India → UNITED STATES13.1%

ImportsUNITED STATES → India$942.1K CANADA → India$171.0K

#1 Supplier: MYLAN LABORATORIES

Emtricitabine Suppliers from India (2026) — 141 Exporters, $119.4M Market | TransData Nexus | TransData Nexus

Who Exports Emtricitabine from India — 141 Suppliers Behind a $119.4M Market

India's emtricitabine export market is supplied by 141 active exporters who collectively shipped $119.4M across 2,194 shipments. MYLAN LABORATORIES LIMITED leads with a 35.6% market share, followed by MACLEODS PHARMACEUTICALS LTD and AUROBINDO PHARMA LTD. The top 5 suppliers together control 83.6% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Emtricitabine Suppliers & Exporters — 141 manufacturers, $119.4M export market, top destinations and formulations — Emtricitabine supplier data — 141 exporters · $119.4M market · 2,194 shipmentsTransData Nexus · Indian Customs Data

Top Emtricitabine Exporters from India — Ranked by Export Value

MYLAN LABORATORIES LIMITED is the leading emtricitabine exporter from India, holding a 35.6% share of the $119.4M market across 2,194 shipments from 141 exporters. The top 5 suppliers — MYLAN LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD, AUROBINDO PHARMA LTD, LUPIN LIMITED, CIPLA LIMITED — collectively control 83.6% of total export value, indicating a highly concentrated market. Individual shares are: MYLAN LABORATORIES LIMITED (35.6%), MACLEODS PHARMACEUTICALS LTD (32.8%), AUROBINDO PHARMA LTD (6.4%), LUPIN LIMITED (5.2%), CIPLA LIMITED (3.8%).

Top Emtricitabine Exporters from India

Ranked by export value · 141 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Emtricitabine Exporters from India — Ranked by Export Value. 141 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1	MYLAN LABORATORIES LIMITED

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Emtricitabine exporters

Certification and compliance status for top Emtricitabine suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Aurobindo Pharma Limited	Warning Letter, January 2	Yes, multiple produc	Unknown	Multiple, including Emtricitabine Capsules 200mg	Received FDA warning letter in January 2022 for CGMP deviations; WHO prequalifie
Mylan Laboratories Limited	Approved	Yes, multiple produc	Unknown	Multiple, including Emtricitabine/Tenofovir alafenamide Tablet 200mg/25mg	WHO prequalified Emtricitabine/Tenofovir alafenamide tablets; no FDA warning let
Macleods Pharmaceuticals Ltd	Approved	Yes, multiple produc	Unknown	Multiple, including Emtricitabine/Tenofovir disoproxil fumarate Tablet 200mg/300mg	WHO prequalified Emtricitabine/Tenofovir disoproxil fumarate tablets; no FDA war
Lupin Limited	Approved	Yes, multiple produc	Unknown	Multiple	WHO prequalified Moxifloxacin and Atazanavir/Ritonavir tablets; no FDA warning l
Hetero Labs Limited	Approved	Yes, multiple produc	Unknown	Multiple	WHO prequalified Dolutegravir/Lamivudine/Tenofovir disoproxil fumarate tablets;
Strides Pharma Science Limited	Approved	Yes, multiple produc	Unknown	Multiple	WHO prequalified Emtricitabine/Tenofovir disoproxil fumarate tablets; no FDA war
Emcure Pharmaceuticals Limited	Approved	Yes, multiple produc	Unknown	Multiple	WHO prequalified Dolutegravir and Dolutegravir/Lamivudine/Tenofovir disoproxil f
Laurus Labs Limited	Approved	Yes, multiple produc	Unknown	Multiple	WHO prequalified Efavirenz/Emtricitabine/Tenofovir disoproxil fumarate tablets;

TransData Nexus reviewed the regulatory standing of 8 leading Emtricitabine exporters from India. 7 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 0 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Emtricitabine sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes approximately 40% of the country's bulk drug production. The city hosts over 2,000 pharmaceutical companies, including major players like Aurobindo Pharma Ltd and Dr. Reddy’s Laboratories. The establishment of Genome Valley, a premier biotech cluster, has further solidified Hyderabad's position as a global hub for pharmaceutical manufacturing and research.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports. Vadodara, in particular, is home to Alembic Pharmaceuticals, one of India's oldest pharmaceutical companies, established in 1907. The region's robust infrastructure and skilled workforce have attracted numerous pharmaceutical companies, making it a significant hub for drug formulations.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates the export of pharmaceutical products to various international markets. The region hosts several pharmaceutical companies, including Cipla Limited, which has a notable share in Emtricitabine exports. The strategic location and well-developed logistics infrastructure make this cluster pivotal for the distribution of pharmaceutical products globally.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Emtricitabine exporters from India

May 2023

M&A

Lupin Limited — Lupin acquires French pharmaceutical company Medisol

In May 2023, Lupin Limited announced the acquisition of Medisol, a French pharmaceutical company, aiming to strengthen its presence in the European market. - IMPACT: This acquisition is expected to enhance Lupin's distribution network in Europe, potentially increasing Emtricitabine exports to the region.

Impact: This acquisition is expected to enhance Lupin's distribution network in Europe, potentially increasing Emtricitabine exports to the region.

May 2024

Collaboration

Aurobindo Pharma Limited — Aurobindo's TheraNym Biologics partners with Merck for biologics manufacturing

In May 2024, TheraNym Biologics, a wholly owned subsidiary of Aurobindo Pharma, signed an agreement with Merck & Co. to expand its biologics manufacturing facilities and explore contract manufacturing operations for biologics. - IMPACT: This collaboration may lead to increased production capabilities, potentially boosting Emtricitabine exports.

Impact: This collaboration may lead to increased production capabilities, potentially boosting Emtricitabine exports.

Common Questions — Emtricitabine Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which emtricitabine supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, MYLAN LABORATORIES LIMITED leads with 265 recorded shipments worth $42.5M. MACLEODS PHARMACEUTICALS LTD (280 shipments) and AUROBINDO PHARMA LTD (118 shipments) are also established high-volume exporters.

Q How many emtricitabine manufacturers are there in India?

India has 141 active emtricitabine exporters with a combined export market of $119.4M across 2,194 shipments to 117 countries. The top 5 suppliers hold 83.6% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for emtricitabine from India?

Average FOB unit price: $11.21 per unit, ranging from $0.00 to $1153.61. Average shipment value: $54.4K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Emtricitabine

Emtricitabine

Who Exports Emtricitabine from India — 141 Suppliers Behind a $119.4M Market

Top Emtricitabine Exporters from India — Ranked by Export Value

Top Emtricitabine Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Lupin Limited — Lupin acquires French pharmaceutical company Medisol

Aurobindo Pharma Limited — Aurobindo's TheraNym Biologics partners with Merck for biologics manufacturing

Common Questions — Emtricitabine Suppliers from India

Q Which emtricitabine supplier from India is the most reliable for bulk orders?

Q How many emtricitabine manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for emtricitabine from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Cipla Limited — Cipla receives US FDA approval for Glucagon ANDA

Analysis Methodology